118 related articles for article (PubMed ID: 22993356)
1. Feasibility of concurrent chemoradiotherapy with S-1 administered on alternate days for elderly patients with head and neck cancer.
Kogashiwa Y; Nagafuji H; Kohno N
Anticancer Res; 2012 Sep; 32(9):4035-40. PubMed ID: 22993356
[TBL] [Abstract][Full Text] [Related]
2. Phase I study of oral S-1 and concurrent radiotherapy in patients with head and neck cancer.
Nakata K; Sakata K; Someya M; Miura K; Hayashi J; Hori M; Takagi M; Himi T; Kondo A; Hareyama M
J Radiat Res; 2013 Jul; 54(4):679-83. PubMed ID: 23292146
[TBL] [Abstract][Full Text] [Related]
3. Analysis of feasibility and toxicity of concurrent chemoradiotherapy with S-1 for locally advanced squamous cell carcinoma of the head and neck in elderly cases and/or cases with comorbidity.
Tsukuda M; Ishitoya J; Mikami Y; Matsuda H; Horiuchi C; Taguchi T; Satake K; Kawano T; Takahashi M; Nishimura G; Kawakami M; Sakuma Y; Watanabe M; Shiono O; Komatsu M; Yamashita Y
Cancer Chemother Pharmacol; 2009 Oct; 64(5):945-52. PubMed ID: 19219603
[TBL] [Abstract][Full Text] [Related]
4. Consecutive daily low-dose S-1 adjuvant chemotherapy after radical treatment for squamous cell carcinoma in head and neck cancer.
Furusaka T; Tanaka A; Matsuda H; Ikeda M
Acta Otolaryngol; 2011 Oct; 131(10):1099-103. PubMed ID: 21651316
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and toxicity of adjuvant chemotherapy using S-1 granules for local advanced squamous cell carcinoma of the head and neck.
Suzuki S; Honda K; Sato T; Yamazaki K; Ishikawa K
J Chemother; 2015 Oct; 27(5):297-300. PubMed ID: 25971448
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma.
Kim HS; Kim HR; Kim GM; Kim HS; Koh YW; Kim SH; Choi EC; Hong YK; Sung JH; Kim SM; Kim JH; Cho BC
Cancer Chemother Pharmacol; 2012 Oct; 70(4):539-46. PubMed ID: 22868340
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of interim FDG-PET after induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck receiving sequential induction chemotherapy followed by concurrent chemoradiotherapy.
Yoon DH; Cho Y; Kim SY; Nam SY; Choi SH; Roh JL; Lee SW; Song SY; Lee JH; Kim JS; Cho KJ; Kim SB
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):118-25. PubMed ID: 20675065
[TBL] [Abstract][Full Text] [Related]
9. Outpatient oral chemotherapy with S-1 for unresectable or distant metastatic head and neck cancer.
Maeda M; Yamashita T; Matsunobu T; Araki K; Tomifuji M; Shiotani A
Anticancer Res; 2013 Aug; 33(8):3285-9. PubMed ID: 23898093
[TBL] [Abstract][Full Text] [Related]
10. [Adjuvant chemotherapy with S-1 for advanced head and neck carcinoma].
Tsukuda M; Ishitoya J; Mikami Y; Matsuda H; Katori H; Horiuchi C; Taguchi T; Yoshida T; Toth G
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():172-8. PubMed ID: 16897997
[TBL] [Abstract][Full Text] [Related]
11. Concomitant chemoradiotherapy using carboplatin, tegafur-uracil and leucovorin for stage III and IV head-and-neck cancer: results of GORTEC Phase II study.
Fesneau M; Pointreau Y; Chapet S; Martin L; Pommier P; Alfonsi M; Laguerre B; Feham N; Berger C; Garaud P; Calais G
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):154-63. PubMed ID: 19386430
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of S-1 chemotherapy in recurrent/metastatic head and neck cancer.
Suzuki S; Ishikawa K
J Infect Chemother; 2009 Oct; 15(5):335-9. PubMed ID: 19856075
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck squamous cell carcinoma.
Okuda H; Ohnishi M; Takahashi H; Takagi C; Takada N; Ohashi T
Auris Nasus Larynx; 2019 Dec; 46(6):882-888. PubMed ID: 31176493
[TBL] [Abstract][Full Text] [Related]
14. [Concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma].
Ikeda Y; Tsukuda M; Tanigaki Y; Yabuki K; Mitake D; Ishitoya J
Gan To Kagaku Ryoho; 2008 May; 35(5):789-92. PubMed ID: 18487914
[TBL] [Abstract][Full Text] [Related]
15. Critical evaluation of a prospective study of concurrent chemoradiotherapy with S-1 for early glottic carcinoma.
Kimura K; Itoh Y; Okada T; Nakahara R; Kawamura M; Kubota S; Itoh J; Hiramatsu M; Fujimoto Y; Shibata T; Naganawa S
Anticancer Res; 2015 Apr; 35(4):2385-90. PubMed ID: 25862904
[TBL] [Abstract][Full Text] [Related]
16. [Early phase II study of S-1 in patients with advanced head and neck cancer. S-1 Cooperative Study Group (Head and Neck Working Group)].
Inuyama Y; Kida A; Tsukuda M; Kohno N; Satake B
Gan To Kagaku Ryoho; 1998 Jul; 25(8):1151-8. PubMed ID: 9679577
[TBL] [Abstract][Full Text] [Related]
17. S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.
Yokota T; Onozawa Y; Boku N; Hamauchi S; Tsushima T; Taniguchi H; Todaka A; Machida N; Yamazaki K; Fukutomi A; Yasui H
Jpn J Clin Oncol; 2011 Dec; 41(12):1351-7. PubMed ID: 21980053
[TBL] [Abstract][Full Text] [Related]
18. A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer.
Ikeda M; Ioka T; Ito Y; Yonemoto N; Nagase M; Yamao K; Miyakawa H; Ishii H; Furuse J; Sato K; Sato T; Okusaka T
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):163-9. PubMed ID: 22677367
[TBL] [Abstract][Full Text] [Related]
19. Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604).
Tahara M; Fuse N; Mizusawa J; Sato A; Nihei K; Kanato K; Kato K; Yamazaki K; Muro K; Takaishi H; Boku N; Ohtsu A
Cancer Sci; 2015 Oct; 106(10):1414-20. PubMed ID: 26250827
[TBL] [Abstract][Full Text] [Related]
20. Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer.
Tsukuda M; Kida A; Fujii M; Kono N; Yoshihara T; Hasegawa Y; Sugita M;
Br J Cancer; 2005 Oct; 93(8):884-9. PubMed ID: 16189518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]